Trials / Completed
CompletedNCT06018571
Burden of Illness and Treatment Assessment of Patients With Dry Eye Disease: A Cross-Sectional Survey of Real-World Patients With Dry Eye Disease in the US
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 946 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study employed secondary database analysis of the Adelphi Dry Eye Disease (DED) Disease Specific Programme™ (DSP™), a templatized cross-sectional survey with retrospective data collection that is administered by Adelphi to a convenience sample of patients diagnosed with DED, and their consulting physicians in the United States. In addition to the survey data, the DED DSP also included recorded medical history data as reported by physicians (optometrists, ophthalmologists or refractive surgeons).
Conditions
Timeline
- Start date
- 2022-06-02
- Primary completion
- 2022-08-19
- Completion
- 2022-08-19
- First posted
- 2023-08-30
- Last updated
- 2023-08-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06018571. Inclusion in this directory is not an endorsement.